The microinjection of a cannabinoid agonist into the accumbens shell induces anxiogenesis in the elevated plus-maze

Pharmacology Biochemistry and Behavior

Volumn 124, Issue , 2014, Pages 160-166

  Kochenborger, Larissa ^a   Levone, Brunno Rocha ^a   Da Silva, Eduardo Simão ^a   Taschetto, Ana Paula Dambros ^a   Terenzi, Mariana Graciela ^a   Paschoalini, Marta Aparecida ^a   Faria, Moacir Serralvo ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

ACEA; Anxiety; Elevated plus maze; Nucleus accumbens

Indexed keywords

ARACHIDONYL 2' CHLOROETHYLAMIDE; CANNABINOID 1 RECEPTOR AGONIST; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL-2-CHLOROETHYLAMIDE; CANNABINOID;

ACCUMBENS SHELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELEVATED PLUS MAZE TEST; HISTOLOGY; LATERAL BRAIN VENTRICLE; LOCOMOTION; MALE; MICROINJECTION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; MAZE TEST; WISTAR RAT;

ANIMALS; ANXIETY; ARACHIDONIC ACIDS; CANNABINOIDS; MALE; MAZE LEARNING; MICROINJECTIONS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR;

EID: 84903200214     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.05.017     Document Type: Article

References (81)

1. E.D. Abercrombie, K.A. Keefe, D.S. DiFrischia, and M.J. Zigmond Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens and medial prefrontal cortex J Neurochem 52 1989 1655 1658
2. I. Akirav Targeting the endocannabinoid system to treat haunting traumatic memories Front Behav Neurosci 7 2013 124
3. I. Akirav Cannabinoids and glucocorticoids modulate emotional memory after stress Neurosci Biobehav 37 2013 2554 2563
4. T. Anastasio Computational search for hypotheses concerning the endocannabinoid contribution to the extinction of fear conditioning Front Comput Neurosci 7 2013 74
5. L.M. Annet, A. Mcgregor, and T.W. Robbins The effects of ibotenic acid lesions of the nucleus accumbens on spatial learning and extinction in the rat Behav Brain Res 31 1989 231 242
6. K. Basar, T. Sesia, H. Groenewegen, H.W.M. Steinbusch, V. Visser-Vandewalle, and Y. Temel Nucleus accumbens and impulsivity Prog Neurobiol 92 2010 533 557
7. A.M. Basso, and A.E. Kelley Feeding induced by GABAA receptor stimulation within the nucleus accumbens shell: regional mapping and characterization of macronutrient and taste preference Behav Neurosci 113 1999 324 336
8. A. Bilkei-Gorzo The endocannabinoid system in normal and pathological brain ageing Philos Trans R Soc B 367 1607 2012 3326 3334
9. M. Bortolato, P. Campolongo, R.A. Mangieri, M.L. Scattoni, R. Frau, and V. Trezza et al. Anxiolytic-like properties of the anandamide transport inhibitor AM404 Neuropsychopharmacology 31 2006 2652 2659
10. D. Braida, V. Limonta, L. Malabarba, A. Zani, and M. Sala 5-HT1A receptors are involved in the anxiolytic effect of delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats Eur J Pharmacol 555 2007 156 163
11. A.C. Campos, F.R. Ferreira, F.S. Guimarães, and J.I. Lemos Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience Neuroscience 167 2010 238 246
12. A.F. Carvalho, K. Mackie, and E.J. Van Bockstaele Cannabinoid modulation of limbic forebrain noradrenergic circuitry Eur J Neurosci 31 2 2010 286 301
13. J.F. Cheer, K.M. Wassum, M.L.A.V. Heien, P.E.M. Phillips, and R.M. Wightman Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats J Neurosci 24 18 2004 4393 4400
14. J. Chen, W. Paredes, J.H. Lowinson, and E.L. Gardner Δ9- Tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex Eur J Pharmacol 190 1990 259 262
15. 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study Neurosci Lett 129 1991 136 140
16. J.R. Clapper, R.A. Mangieri, and D. Piomelli The endocannabinoid system as a target for the treatment of cannabis dependence Neuropharmacology 56 2009 235 243
17. I.C. Da Cunha, A.M. De Nazareth, J.C. Vargas, A. Ferraz, J.M. Neto, and M.A. Paschoalini et al. The microinjection of AMPA receptor antagonist into the accumbens shell failed to change food intake, but reduced fear-motivated behaviour in free-feeding female rats Behav Brain Res 193 2008 243 247
18. I.C. Da Cunha, A.P.F. Lopes, S.M. Steffens, A. Ferraz, J.C. Vargas, and T.C.M. De Lima et al. The microinjection of AMPA receptor antagonist into the accumbens shell, but not into the accumbens core, induces anxiolysis in an animal model of anxiety Behav Brain Res 188 2008 91 99
19. G. Damsma, J.G. Pfaus, D. Wenkstern, A.G. Phillips, and H.C. Fibiger Sexual behavior increases dopamine transmission in the nucleus accumbens and striatum of male rats: comparison with novelty and locomotion Behav Neurosci 106 1992 181 191
20. V. Di Marzo, D. Melck, T. Bisogno, and L. De Petrocellis Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action Trends Neurosci 21 12 1998 521 528
21. L.M. Dono, and P.J. Currie The cannabinoid receptor CB1 inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala Neuropharmacology 62 2012 192 199
22. M. ElBatsh, N. Assareh, C.A. Marsden, and D.A. Kendall Anxiogenic-like effects of chronic cannabidiol administration in rats Psychopharmacology (Berl) 221 2 2012 239 247
23. S.E. File Behavioural detection of anxiolytic action J.M. Elliott, D.J. Heal, C.A. Marsden, Experimental approaches to anxiety and depression 1992 John Willey & Sons New York 25 44
24. J.M. Finlay, G. Damsma, and H.C. Fibiger Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration Psychopharmacology (Berl) 106 2 1992 202 208
25. P.A. Gargiulo Thyrotropin releasing hormone injected into the nucleus accumbens septi selectively increases face grooming in rats Braz J Med Biol Res 29 1996 805 810
26. R.F. Genn, S. Tucci, E.M. Marco, M.P. Viveros, and S.E. File Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test Pharmacol Biochem Behav 77 2004 567 573
27. E. Giné, V. Echeverry-Alzate, J.Á. López-Moreno, A. López-Jimenez, D. Torres-Romero, and A. Perez-Castillo et al. Developmentally-induced hypothyroidism alters the expression of Egr-1 and Arc genes and the sensitivity to cannabinoid agonists in the hippocampus. Possible implications for memory and learning Mol Cell Endocrinol 365 1 2013 119 128
28. V.M.C. Guimarães, A.W. Zuardi, E.A. Del Bel, and F.S. Guimarães Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum Life Sci 75 2004 633 638
29. J. Haller, B. Varga, C. Ledent, and T.F. Freund CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents Behav Pharmacol 15 2004 299 304
30. D. Hauer, I. Kaufmann, C. Strewe, I. Briegel, P. Campolongo, and G. Schelling The role of glucocorticoids, catecholamines and endocannabinoids in the development of traumatic memories and posttraumatic stress symptoms in survivors of critical illness Neurobiol Learn Mem 112 2014 68 74
31. L. Heimer, D.S. Zahm, L. Churchill, P.W. Kalivas, and C. Wohltmann Specificity in the projection patterns of accumbal core and shell in the rat Neuroscience 41 1991 89 125
32. H. Hermann, G. Marsicano, and B. Lutz Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain Neuroscience 109 3 2002 451 460
33. M.N. Hill, and B.B. Gorzalka Enhancement of anxiety-like responsiveness to the cannabinoid CB1 receptor agonist HU-210 following chronic stress Eur J Pharmacol 499 3 2004 291 295
34. P.W. Kalivas, and P. Duffy Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress Brain Res 675 1995 325 328
35. L. Kochenborger, D. Zanatta, L.M. Berretta, A.P.F. Lopes, B.L. Wunderlich, and A.C. Januário et al. Modulation of fear/anxiety responses, but not food intake, following α-adrenoceptor agonist microinjections in the nucleus accumbens shell of free-feeding rats Neuropharmacology 62 1 2012 427 435
36. G.F. Koob The neurocircuitry of addiction: implications for treatment Clin Neurosci Res 5 2005 89 101
37. G.F. Koob Negative reinforcement in drug addiction: the darkness within Curr Opin Neurobiol 23 2013 559 563
38. S.F. Lisboa, L.B. Resstel, D.C. Águia, and F.S. Guimarães Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test Eur J Pharmacol 593 2008 73 78
39. A.P.F. Lopes, I.C. Da Cunha, S.M. Steffens, A. Ferraz, J.C. Vargas, and T.C.M. De Lima et al. GABAA and GABAB agonist microinjections into medial accumbens shell increase feeding and induce anxiolysis in an animal model of anxiety Behav Brain Res 184 2007 142 149
40. A.P.F. Lopes, L. Ganzer, A.C. Borges, L. Kochenborger, A.C. Januário, and M.S. Faria et al. Effects of GABA ligands injected into the nucleus accumbens shell on fear/anxiety-like and feeding behaviours in food-deprived rats Pharmacol Biochem Behav 101 1 2012 41 48
41. O.J. Manzoni, and J. Bockaert Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens Eur J Pharmacol 412 2001 R3 R5
42. S. Marín, E. Marco, M. Biscaia, B. Fernández, M. Rubio, and C. Guaza et al. Involvement of the k-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats Pharmacol Biochem Behav 74 3 2003 649 656
43. L.D. McCullough, and J.D. Salamone Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens Psychopharmacology (Berl) 109 3 1992 379 382
44. R.J. McLaughlin, and G. Gobbi Cannabinoids and emotionality: a neuroanatomical perspective Neuroscience 204 2012 134 144
45. R. Mechoulam, and L.A. Parker The endocannabinoid system and the brain Annu Rev Psychol 64 1 2013 21 47
46. F.A. Moreira, D.C. Aguiar, and F.S. Guimarães Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray Neuropharmacology 52 2007 958 965
47. T. Murai, Y. Yoshida, S. Koide, K. Takada, T. Misaki, and N. Koshikawa et al. Clonidine reduces dopamine and increases GABA in the nucleus accumbens: an in vivo microdialysis study Pharmacol Biochem Behav 60 1998 695 701
48. A. Neumeister The endocannabinoid system provides as avenue for evidence-based treatment development for PTSD Depress Anxiety 30 2 2013 93 96
49. E.B. Ottoni EthoLog 2.2: a tool for the transcription and timing of behavior observation sessions Behav Res Methods Instrum Comput 32 2000 446 449
50. S. Patel, and C.J. Hillard Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling J Pharmacol Exp Ther 318 2006 304 311
51. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 2007 Academic Press
52. M.A. Pezze, and J. Feldon Mesolimbic dopaminergic pathways in fear conditioning Prog Neurobiol 74 2004 301 320
53. S.M. Reynolds, and K.C. Berridge Fear and feeding in the nucleus accumbens shell: rotrocaudal segregation of GABA-elicited defensive behavior versus eating behavior J Neurosci 21 2001 3261 3270
54. S.M. Reynolds, and K.C. Berridge Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste "liking"/"disliking" reactions, place preference/avoidance, and fear J Neurosci 22 2002 7308 7320
55. S.M. Reynolds, and K.C. Berridge Glutamate motivational ensembles in nucleus accumbens: rostrocaudal shell gradients of fear and feeding Eur J Neurosci 17 2003 2187 2200
56. A. Ribeiro, V. Ferraz-De-Paula, M.L. Pinheiro, and J. Palermo-Neto Dose-response effects of systemic anandamide administration in mice sequentially submitted to the open field and elevated plus-maze tests Braz J Med Biol Res 42 2009 556 560
57. C.J. Riebe, and C.T. Wotjak Endocannabinoids and stress Stress 14 2011 384 397
58. R.J. Rodgers, and A. Dalvi Anxiety, defence and the elevated plus-maze Neurosci Biobehav Rev 21 1997 801 810
59. R.J. Rodgers, and N.J.T. Johnson Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety Pharmacol Biochem Behav 52 1995 297 303
60. R.J. Rodgers, B.-J. Cao, A. Dalvi, and A. Holmes Animal models of anxiety: an ethological perspective Braz J Med Biol Res 30 1997 289 304
61. R.J. Rodgers, J. Haller, A. Holmes, J. Halasz, T.J. Walton, and P.F. Brain Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice Physiol Behav 68 1999 47 53
62. A. Roohbakhsh, A.H. Moghaddam, R. Massoudi, and M.R. Zarrindast Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test Clin Exp Pharmacol Physiol 34 2007 223 229
63. A. Roohbakhsh, S. Keshavarz, P. Hasanein, M.E. Rezvani, and A.H. Moghaddam Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours Basic Clin Pharmacol Toxicol 105 2009 333 338
64. T. Rubino, M. Sala, D. Viganò, D. Braida, C. Castiglioni, and V. Limonta et al. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats Neuropsychopharmacology 32 2007 2036 2045
65. M. Rutkowska, J. Jamontt, and H. Gliniak Effects of cannabinoids on the anxiety-like response in mice Pharmacol Rep 58 2006 200 206
66. J.D. Salamone The involvement of nucleus accumbens dopamine in appetitive and aversive motivation Behav Brain Res 61 1994 117 133
67. M. Scherma, J. Medalie, W. Fratta, S.K. Vadivel, A. Makriyannis, and D. Piomelli et al. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition Neuropharmacology 54 2008 129 140
68. N. Schramm-Sapyta, Y. Cha, S. Chaudhry, W. Wilson, H.S. Swartzwelder, and C. Kuhn Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats Psychopharmacology (Berl) 191 4 2007 867 877
69. J.K. Seamans, and A.G. Phillips Selective memory impairments produced by transient lidocaine-induced lesions of the nucleus accumbens in rats Behav Neurosci 108 1994 456 468
70. B. Setlow, and J.L. Mcgaugh Sulpiride infused into the nucleus accumbens posttraining impairs memory of spatial water maze training Behav Neurosci 112 1998 603 610
71. K.S. Sink, K.N. Segovia, J. Sink, P.A. Randall, L.E. Collins, and M. Correa et al. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142 Eur Neuropsychopharmacol 20 2010 112 122
72. B.T. Sperlágh, K. Windisch, R.M.D. Andó, and Vizi E. Sylvester Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens Neurochem Int 54 7 2009 452 457
73. S. Tambaro, M.L. Tomasi, and M. Bortolato Long-term CB1 receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids Neuropharmacology 70 2013 268 277
74. G. Tanda, F.E. Pontieri, and G. Di Chiara Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism Science 276 5321 1997 2048 2050
75. V. Trezza, and P. Campolongo The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder Front Behav Neurosci 7 2013 100
76. K. Tsou, S. Brown, M.C. Sañudo-Peña, K. Mackie, and J.M. Walker Immunohistochemical distribution of cannabinoid cb1 receptors in the rat central nervous system Neuroscience 83 1998 393 411
77. A. Usiello, F. Sargolini, P. Roullet, M. Amassari-Teule, E. Passino, and A. Oliverio et al. N-Methyl-d-aspartate receptors in the nucleus accumbens are involved in detection of spatial novelty in mice Psychopharmacology (Berl) 137 1998 175 183
78. M.P. Viveros, E.M. Marco, and S.E. File Endocannabinoid system and stress and anxiety responses Pharmacol Biochem Behav 81 2005 331 342
79. J.M. Witkin, E.T. Tzavara, and G.G. Nomikos A role for cannabinoid CB1 receptors in mood and anxiety disorders Behav Pharmacol 16 5-6 2005 315 331
80. D.S. Zahm, and J.S. Brog On the significance of subterritories in the "accumbens" part of the rat ventral striatum Neuroscience 50 1992 751 767
81. M.R. Zarrindast, S. Sarahroodi, A. Arzi, M.J. Khodayar, S. Taheri-Shalmani, and A. Rezayof Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system Behav Pharmacol 19 2008 716 723 Nível Superior